Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NanoValent Pharmaceuticals Logo
NanoValent Pharmaceuticals Growth Score
47
CB Rank
549559
Heat Score
25
NanoValent Pharmaceuticals is a pharmaceutical company.
Founded
obfuscation
PrivateGrant Bozeman, Montana, United States11-50 nanovalent.com
Biotechnology
Pharmaceutical
Therapeutics
Overview

NanoValent Pharmaceuticals
Total Funding
obfuscation
Growth Score
47
Heat Score
25

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score47
-2 pts
in past quarter
Heat Score 25
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NanoValent Pharmaceuticals

CB Rank
549559
NanoValent Pharmaceuticals is a pharmaceutical company.
Founded
obfuscation
PrivateGrant Bozeman, Montana, United States11-50 nanovalent.com
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation

Details

Legal Name NanoValent Pharmaceuticals, Inc.
Also Known As NVP
Operating Status Active
Company Type For Profit
About the Company
NanoValent Pharmaceuticals develops novel therapeutic options with enhanced target and delivery characteristics. Their technology will significantly enhance therapeutics. It possesses an experienced core management team with a proven track record of success, supported by a strong clinical and operational capability.
Phone Number +1 406 586 8420
Contact Email mlewis@nanovalent.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

TARGETED NANOSPHERE (TNS) platform
A nanosphere-based drug delivery platform designed to improve delivery, safety, and performance of cancer and other therapeutics.
NV103
A lead product candidate based on the TNS platform, advancing toward investigational new drug (IND) and clinical status.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - NanoValent Pharmaceuticals Logo
Grant - NanoValent Pharmaceuticals
1
obfuscation
National Science FoundationGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 3
News
Technology
View Tech Report

IT Spend

$27.6KThis year, NanoValent Pharmaceuticals is projected to spend $27.6K on IT, according to Aberdeen.

Active Website Tech Count

3NanoValent Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 100m.

Total IP

7The intellectual property of NanoValent Pharmaceuticals includes 7 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NanoValent Pharmaceuticals's headquarters? NanoValent Pharmaceuticals is located in Bozeman, Montana, United States.Who invested in NanoValent Pharmaceuticals? NanoValent Pharmaceuticals is funded by National Science Foundation.When was the last funding round for NanoValent Pharmaceuticals? NanoValent Pharmaceuticals closed its last funding round on
obfuscation
from a Grant round.Who are NanoValent Pharmaceuticals's competitors? Alternatives and possible competitors to NanoValent Pharmaceuticals may include Moderna, ImmunityBio, and  Nanobiotix.How much funding has NanoValent Pharmaceuticals raised to date? NanoValent Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|